Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Home-based cortical stimulation for chronic neuropathic pain relief

Official title: Non-invasive Analgesic Stimulation of the Motor Cortex at Home

Run by Hospices Civils de Lyon · NCT02346396 · Data updated 2026-11-12

This study is testing whether a home-based brain stimulation treatment can help people with chronic nerve pain who haven't found relief from regular medications.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment40 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations1 site (Bron)
StatusRecruiting
StartedFebruary 9, 2015
Main results expectedMay 9, 2027
Study endsMay 9, 2027
Registry record updatedJanuary 2, 2024
Trial IDNCT02346396 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 80 with pharmacoresistant neuropathic chronic pain lasting over one year.

Probably not a fit

Patients with a history of drug addiction, epilepsy, or those with intracranial ferromas may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to evaluate the effectiveness of transcranial direct current stimulation (tDCS) in alleviating chronic neuropathic pain in patients who have not responded to conventional medications. The study will assess the analgesic effects of tDCS when administered at home, focusing on the importance and duration of pain relief achieved through repeated sessions over several weeks. By utilizing a non-invasive approach, the study seeks to improve the efficiency of pain management for individuals suffering from long-term neuropathic pain.

Why it matters

Potential benefit: If successful, this approach could provide a new, effective, and non-invasive treatment option for patients with chronic neuropathic pain.

How similar studies have gone: While this approach is relatively novel, previous studies have shown promise in using tDCS for pain management, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria :

* Patients from 18 to 80 years old, men or women, suffering pharmaco-resistant neuropathic chronic pain for more than one year; NVS \> 2 during the week S0) unilateral pharmacoresistant, whose analgesic treatment is stable for at least 1 month.
* Patients whose pharmacoresistance leads their referent doctor to consider non-pharmacological therapeutic alternatives and begin a presurgical assessment.
* Patients having an operational Internet connection. The patient or one person of its circle of acquaintances will have to be able to connect on the Internet and to reach by this way the system of relocated stimulation ("The Cloud").
* Patients having shown pain relief to a single- or whole-week sessions of tDCS are not excluded from potential recruitment for this study.
* Patients having a social security cover.
* Patients having given their written consent.

Exclusion Criteria :

* History
* of addiction to drugs,
* of epilepsy.
* Présence of an intra-cranial ferromagnetic equipment or of an implanted stimulation device (e.g. stimulating, central grey pacemaker, stimulation of the basal ganglia or of the vagus nerve).
* Introduction of a new analgesic treatment for less than a month.
* Lack of a effective contraception for all the duration of the study for the patients old enough to procreate.

(No limitation in the inclusion of male patients old enough to procreate).

* Patient under legal protective measure.
* Pregnant women and nursing mothers

Where it's running

  • Hospices Civils de Lyon - Neurological Hospital - University Pain Clinic (CETD)
    Bron, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.